Nicki Packer FRSC, is a Distinguished Professor at Macquarie University. Her research career has covered a wide range of analytical proteomics and glycomics across diverse biological projects. She co-founded the Australian Proteome Analysis Facility (APAF), and for 8 years was a founding shareholder and executive of Proteome Systems Ltd, an Australian biotechnology company using proteomics and glycomics to develop, manufacture and sell technology and informatics to discover biomarkers of disease. In 2007 she returned to Macquarie University as Professor of Glycoproteomics and Director of MQ Biomolecular Frontiers Research Centre as part of recruitment for their Concentrations of Research Excellence, and since 2017 has a joint appointment at the Institute for Glycomics, Griffith University. Nicki has published her research extensively (h-index 80, Citations 26898 in March 2024) and works closely with industry. She was Deputy Director of the ARC Industrial Transformation Training Centre for Molecular Technology in the Food Industry and was Discovery Theme Leader of the ARC Centre of Excellence in NanoBioPhotonics (CNBP). From 2020 she is now a Chief Investigator in the ARC Centre of Excellence in Synthetic Biology and from 2021 is a CI in the ARC Facilitated Advancement of Australia's Bioactives (FAAB) Industrial Transformation Training Centre and is Academic Lead of the Australian Proteome Analysis Facility. Her research role in all her work is directed towards the role of glycosylation in health and disease; specifically her current projects encompass the improved analysis, and role of glycosylation, in many systems including the i) analysis and function of glycans attached to glycoproteins, glycolipids and proteoglycans, ii) cell membrane glycosylation interactions, iii) glycans as targets for bioimaging and drugs, iv) the mucin glycome-microbiome connection, v) glycoinformatics. Her other achievements include producing 3 reasonably well-balanced children.